BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 8, 1997
View Archived Issues
Genentech Discontinues IGF-1 Development For Diabetes
Read More
Senate Begins Debate On FDA Reform; Vote Expected Tuesday
Read More
IDEC Expects Rituxan Approval In $45M Fund-Raising Scheme
Read More
New Genzyme Cancer Unit Raises $20M In Private Placement Prior To IPO
Read More
Phase II Study Successful For Transgenic Blood Protein
Read More
BioWorld Phase III Report Product Update Survey
Read More
Knocking Out Mutant Virulence Genes In Candida albicans Leaves Mice Alive, Well
Read More
Other News To Note
Read More